+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Live Cell Imaging Market Research Report by Product & Service, Technology, Application, End-User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

  • PDF Icon

    Report

  • 121 Pages
  • January 2023
  • Region: United States
  • 360iResearch™
  • ID: 5722360
The United States Live Cell Imaging Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Live Cell Imaging Market.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States Live Cell Imaging Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States Live Cell Imaging Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States Live Cell Imaging Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the United States Live Cell Imaging Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States Live Cell Imaging Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product & Service, the market is studied across Consumables, Instruments, Services, and Software. The Consumables is is further studied across Assay Kits, Media, and Reagents. The Instruments is is further studied across Accessories, Cell Analyzers, Microscopes, and Standalone Systems.
  • Based on Technology, the market is studied across Fluorescence Recovery After Photobleaching, Fluorescence Resonance Energy Transfer, High-content screening, and Time-lapse Microscopy.
  • Based on Application, the market is studied across Cell Biology, Developmental Biology, Drug Discovery, and Stem Cells.
  • Based on End-User, the market is studied across Academic & Research Institutes, Contract Research Organizations (CROs), and Pharmaceutical & Biotechnology Companies.
  • Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the United States Live Cell Imaging Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States Live Cell Imaging Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States Live Cell Imaging Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States Live Cell Imaging Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Live Cell Imaging Market, including Aligned Genetics, Becton, Dickinson and Company, Bruker Corporation, Carl Zeiss AG, CytoSMART Technologies BV, Danaher Corporation, Keyence Corporation, Merck KGaA, NanoEntek America, Inc., Nanolive SA, Nikon Corporation, Olympus Corporation, PerkinElmer Inc., Phase Focus Limited, and Sartorius AG.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Live Cell Imaging Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Live Cell Imaging Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Live Cell Imaging Market?
4. What is the competitive strategic window for opportunities in the United States Live Cell Imaging Market?
5. What are the technology trends and regulatory frameworks in the United States Live Cell Imaging Market?
6. What is the market share of the leading vendors in the United States Live Cell Imaging Market?
7. What modes and strategic moves are considered suitable for entering the United States Live Cell Imaging Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing adoption of high-content screening techniques in the U.S. for drug discovery
5.1.1.2. Rising incidence of cancer in the U.S.
5.1.2. Restraints
5.1.2.1. High cost of high-content screening systems in the United States
5.1.3. Opportunities
5.1.3.1. Growing focus on personalized medicine, and the expansion of biopharmaceutical and biotechnology industries in the U.S.
5.1.4. Challenges
5.1.4.1. Maintaining cell viability and the cellular environment in cell cultures
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Live Cell Imaging Market, by Product & Service
6.1. Introduction
6.2. Consumables
6.3.1. Assay Kits
6.3.2. Media
6.3.3. Reagents
6.3. Instruments
6.4.1. Accessories
6.4.2. Cell Analyzers
6.4.3. Microscopes
6.4.4. Standalone Systems
6.4. Services
6.5. Software

7. Live Cell Imaging Market, by Technology
7.1. Introduction
7.2. Fluorescence Recovery After Photobleaching
7.3. Fluorescence Resonance Energy Transfer
7.4. High-content screening
7.5. Time-lapse Microscopy

8. Live Cell Imaging Market, by Application
8.1. Introduction
8.2. Cell Biology
8.3. Developmental Biology
8.4. Drug Discovery
8.5. Stem Cells

9. Live Cell Imaging Market, by End-User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Contract Research Organizations (CROs)
9.4. Pharmaceutical & Biotechnology Companies

10. California Live Cell Imaging Market
10.1. Introduction

11. Florida Live Cell Imaging Market
11.1. Introduction

12. Illinois Live Cell Imaging Market
12.1. Introduction

13. New York Live Cell Imaging Market
13.1. Introduction

14. Ohio Live Cell Imaging Market
14.1. Introduction

15. Pennsylvania Live Cell Imaging Market
15.1. Introduction

16. Texas Live Cell Imaging Market
16.1. Introduction

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis, By Key Player
17.3. Market Share Analysis, By Key Player
17.4. Product Portfolio Analysis, By Key Player
17.5. Competitive Scenario
17.5.1. Merger & Acquisition
17.5.2. Agreement, Collaboration, & Partnership
17.5.3. New Product Launch & Enhancement
17.5.4. Investment & Funding
17.5.5. Award, Recognition, & Expansion

18. Company Usability Profiles
18.1. Aligned Genetics
18.2. Becton, Dickinson and Company
18.3. Bruker Corporation
18.4. Carl Zeiss AG
18.5. CytoSMART Technologies BV
18.6. Danaher Corporation
18.7. Keyence Corporation
18.8. Merck KGaA
18.9. NanoEntek America, Inc.
18.10. Nanolive SA
18.11. Nikon Corporation
18.12. Olympus Corporation
18.13. PerkinElmer Inc.
18.14. Phase Focus Limited
18.15. Sartorius AG

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES LIVE CELL IMAGING MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES LIVE CELL IMAGING MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES LIVE CELL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UNITED STATES LIVE CELL IMAGING MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES LIVE CELL IMAGING MARKET DYNAMICS
FIGURE 8. UNITED STATES LIVE CELL IMAGING MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES LIVE CELL IMAGING MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT & SERVICE, 2030
FIGURE 12. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
FIGURE 13. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
FIGURE 14. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
FIGURE 15. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
FIGURE 16. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
FIGURE 17. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
FIGURE 18. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY CELL ANALYZERS, 2018-2030 (USD MILLION)
FIGURE 19. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY MICROSCOPES, 2018-2030 (USD MILLION)
FIGURE 20. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY STANDALONE SYSTEMS, 2018-2030 (USD MILLION)
FIGURE 21. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
FIGURE 22. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
FIGURE 23. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 24. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES LIVE CELL IMAGING MARKET COMPETITIVE STRATEGIC WINDOW, BY TECHNOLOGY, 2030
FIGURE 26. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING , 2018-2030 (USD MILLION)
FIGURE 27. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY FLUORESCENCE RESONANCE ENERGY TRANSFER , 2018-2030 (USD MILLION)
FIGURE 28. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY HIGH-CONTENT SCREENING , 2018-2030 (USD MILLION)
FIGURE 29. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY TIME-LAPSE MICROSCOPY, 2018-2030 (USD MILLION)
FIGURE 30. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 31. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 32. UNITED STATES LIVE CELL IMAGING MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 33. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY CELL BIOLOGY, 2018-2030 (USD MILLION)
FIGURE 34. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, 2018-2030 (USD MILLION)
FIGURE 35. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
FIGURE 36. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
FIGURE 37. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 38. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 39. UNITED STATES LIVE CELL IMAGING MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2030
FIGURE 40. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
FIGURE 41. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), 2018-2030 (USD MILLION)
FIGURE 42. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
FIGURE 43. CALIFORNIA LIVE CELL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 44. FLORIDA LIVE CELL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 45. ILLINOIS LIVE CELL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 46. NEW YORK LIVE CELL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 47. OHIO LIVE CELL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 48. PENNSYLVANIA LIVE CELL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 49. TEXAS LIVE CELL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 50. UNITED STATES LIVE CELL IMAGING MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 51. UNITED STATES LIVE CELL IMAGING MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 52. UNITED STATES LIVE CELL IMAGING MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. UNITED STATES LIVE CELL IMAGING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES LIVE CELL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 5. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 6. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 7. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY CONSUMABLES, BY STATE, 2018-2030 (USD MILLION)
TABLE 8. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 9. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY ASSAY KITS, BY STATE, 2018-2030 (USD MILLION)
TABLE 10. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 11. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY MEDIA, BY STATE, 2018-2030 (USD MILLION)
TABLE 12. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 13. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY REAGENTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 14. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY INSTRUMENTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 17. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY ACCESSORIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY CELL ANALYZERS, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY CELL ANALYZERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY MICROSCOPES, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY MICROSCOPES, BY STATE, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY STANDALONE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY STANDALONE SYSTEMS, BY STATE, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY SERVICES, BY STATE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY SOFTWARE, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING , 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING , BY STATE, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY FLUORESCENCE RESONANCE ENERGY TRANSFER , 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY FLUORESCENCE RESONANCE ENERGY TRANSFER , BY STATE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY HIGH-CONTENT SCREENING , 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY HIGH-CONTENT SCREENING , BY STATE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY TIME-LAPSE MICROSCOPY, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY TIME-LAPSE MICROSCOPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY CELL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY CELL BIOLOGY, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY STATE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY STATE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY STEM CELLS, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY STATE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY STATE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES LIVE CELL IMAGING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 53. CALIFORNIA LIVE CELL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 54. CALIFORNIA LIVE CELL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 55. CALIFORNIA LIVE CELL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. CALIFORNIA LIVE CELL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. CALIFORNIA LIVE CELL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. FLORIDA LIVE CELL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 59. FLORIDA LIVE CELL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 60. FLORIDA LIVE CELL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. FLORIDA LIVE CELL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. FLORIDA LIVE CELL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. ILLINOIS LIVE CELL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 64. ILLINOIS LIVE CELL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 65. ILLINOIS LIVE CELL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. ILLINOIS LIVE CELL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. ILLINOIS LIVE CELL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. NEW YORK LIVE CELL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 69. NEW YORK LIVE CELL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 70. NEW YORK LIVE CELL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. NEW YORK LIVE CELL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. NEW YORK LIVE CELL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. OHIO LIVE CELL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 74. OHIO LIVE CELL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 75. OHIO LIVE CELL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. OHIO LIVE CELL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. OHIO LIVE CELL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. PENNSYLVANIA LIVE CELL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 79. PENNSYLVANIA LIVE CELL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 80. PENNSYLVANIA LIVE CELL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. PENNSYLVANIA LIVE CELL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. PENNSYLVANIA LIVE CELL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. TEXAS LIVE CELL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 84. TEXAS LIVE CELL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 85. TEXAS LIVE CELL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. TEXAS LIVE CELL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. TEXAS LIVE CELL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES LIVE CELL IMAGING MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 89. UNITED STATES LIVE CELL IMAGING MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 90. UNITED STATES LIVE CELL IMAGING MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 91. UNITED STATES LIVE CELL IMAGING MARKET RANKING, BY KEY PLAYER, 2022
TABLE 92. UNITED STATES LIVE CELL IMAGING MARKET SHARE, BY KEY PLAYER, 2022
TABLE 93. UNITED STATES LIVE CELL IMAGING MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 94. UNITED STATES LIVE CELL IMAGING MARKET MERGER & ACQUISITION
TABLE 95. UNITED STATES LIVE CELL IMAGING MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 96. UNITED STATES LIVE CELL IMAGING MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 97. UNITED STATES LIVE CELL IMAGING MARKET INVESTMENT & FUNDING
TABLE 98. UNITED STATES LIVE CELL IMAGING MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 99. UNITED STATES LIVE CELL IMAGING MARKET: LICENSE & PRICING

Companies Mentioned

  • Aligned Genetics
  • Becton, Dickinson and Company
  • Bruker Corporation
  • Carl Zeiss AG
  • CytoSMART Technologies BV
  • Danaher Corporation
  • Keyence Corporation
  • Merck KGaA
  • NanoEntek America, Inc.
  • Nanolive SA
  • Nikon Corporation
  • Olympus Corporation
  • PerkinElmer Inc.
  • Phase Focus Limited
  • Sartorius AG

Methodology

Loading
LOADING...